Giusti Sixto, Arrigain Susana, Lopez Rocio, Pomfret Elizabeth, Cervantes Lilia, Schold Jesse D
Division of Renal Disease and Hypertension, Department of Medicine, Anschutz Medical Campus, University of Colorado, Aurora, Colorado.
Division of Transplant Surgery, Department of Surgery, Anschutz Medical Campus, University of Colorado, Aurora, Colorado; Colorado Center for Transplantation Care, Research and Education, Anschutz Medical Campus, University of Colorado, Aurora, Colorado.
Am J Kidney Dis. 2025 Jul;86(1):52-62.e1. doi: 10.1053/j.ajkd.2025.01.013. Epub 2025 Mar 5.
RATIONALE & OBJECTIVE: Hispanics, the largest ethnic minority group in the United States, experience faster progression of chronic kidney disease (CKD) to kidney failure compared with non-Hispanic White individuals (NHW). Hispanic individuals are less likely to be referred for transplant evaluation, to be listed for transplantation, and to receive a transplant. This study compared kidney transplant outcomes between Hispanic individuals and NHW individuals to gain insights into these health disparities.
Retrospective cohort study.
SETTING & PARTICIPANTS: Recipients of kidney transplants between 2010 and 2021 using data from the Scientific Registry of Transplant Recipients.
Hispanic ethnicity compared with NHW.
Death after transplantation and the composite of allograft failure or death.
Cox proportional models adjusted for donor and recipient characteristics.
Among 212,559 kidney allograft recipients, 17% were Hispanic, and 47% were NHW. Hispanic recipients were younger than NHW recipients (mean age, 48.8+14.1 and 53.5+14.0, respectively). The average time on the transplant waitlist was 18.4 months among Hispanic recipients compared with 12.7 months among NHW recipients. Fewer Hispanic recipients (28%) had private health insurance compared with NHW recipients (42%). Hispanic recipients had lower adjusted rates of death and the composite of allograft failure or death compared with NHW recipients (HR, 0.70 [95 % CI, 0.67-0.73]; vs HR, 0.79 [95% CI, 0.76-0.82], respectively). Similar results were observed when comparing Hispanic non-US citizen/US residents to NHW recipients (HR, 0.68 [95 % CI, 0.63-0.74]; vs HR, 0.73 [95% CI, 0.68-0.78], respectively).
Selection bias, migration bias, salmon bias.
Irrespective of citizenship status, Hispanic kidney transplant recipients had lower rates of death and a composite outcome of allograft survival or death compared with NHW recipients. Future research on access to transplantation and rates of CKD progression may be warranted to improve clinical outcomes among individuals of Hispanic ethnicity with kidney disease.
PLAIN-LANGUAGE SUMMARY: Hispanic patients have a higher burden of chronic kidney disease (CKD) and faster progression to kidney failure when compared with non-Hispanic White (NHW) patients. Hispanic patients experience disparities in access to kidney care, making it harder to undergo transplantation. We evaluated outcomes after kidney transplantation in this population with the goal of gaining insights into these health disparities. We found that Hispanic kidney transplant recipients had lower rates of the composite outcome of death or kidney allograft loss compared with NHW recipients. We also observed a similar benefit in the immigrant and undocumented Hispanic population. Future research on access to transplantation and rates of CKD progression may be warranted to improve clinical outcomes among individuals of Hispanic ethnicity with kidney disease.
西班牙裔是美国最大的少数族裔群体,与非西班牙裔白人个体(NHW)相比,其慢性肾脏病(CKD)进展为肾衰竭的速度更快。西班牙裔个体被转介进行移植评估、列入移植名单以及接受移植的可能性较小。本研究比较了西班牙裔个体与NHW个体的肾移植结局,以深入了解这些健康差异。
回顾性队列研究。
使用移植受者科学登记处的数据,纳入2010年至2021年间的肾移植受者。
与NHW相比的西班牙裔种族。
移植后死亡以及移植肾失功或死亡的复合结局。
采用Cox比例模型,并对供体和受体特征进行调整。
在212,559例肾移植受者中,17%为西班牙裔,47%为NHW。西班牙裔受者比NHW受者更年轻(平均年龄分别为48.8±14.1岁和53.5±14.0岁)。西班牙裔受者在移植等待名单上的平均时间为18.4个月,而NHW受者为12.7个月。与NHW受者(42%)相比,拥有私人医疗保险的西班牙裔受者较少(28%)。与NHW受者相比,西班牙裔受者调整后的死亡以及移植肾失功或死亡的复合结局发生率较低(风险比分别为0.70[95%置信区间,0.67 - 0.73];与风险比0.79[95%置信区间,0.76 - 0.82])。在比较西班牙裔非美国公民/美国居民与NHW受者时也观察到了类似结果(风险比分别为0.68[95%置信区间,0.63 - 0.74];与风险比0.73[95%置信区间,0.68 - 0.78])。
选择偏倚、迁移偏倚、鲑鱼偏倚。
无论公民身份如何,与NHW受者相比,西班牙裔肾移植受者的死亡率以及移植肾存活或死亡的复合结局发生率较低。未来可能有必要对移植可及性和CKD进展率进行研究,以改善患有肾脏疾病的西班牙裔个体的临床结局。
与非西班牙裔白人(NHW)患者相比,西班牙裔患者的慢性肾脏病(CKD)负担更高,进展为肾衰竭的速度更快。西班牙裔患者在获得肾脏护理方面存在差异,这使得他们更难接受移植。我们评估了该人群肾移植后的结局,目的是深入了解这些健康差异。我们发现,与NHW受者相比,西班牙裔肾移植受者死亡或移植肾丢失的复合结局发生率较低。我们在移民和无证件的西班牙裔人群中也观察到了类似的益处。未来可能有必要对移植可及性和CKD进展率进行研究,以改善患有肾脏疾病的西班牙裔个体的临床结局。